Business Context and Reporting Period
Company: Prestige Brands Holdings, Inc. (Prestige Consumer Healthcare Inc.)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and nine months ended December 31, 2007
Business Overview: The Company markets, sells, and distributes over-the-counter healthcare, personal care, and household cleaning brands to mass merchandisers, drug stores, and supermarkets primarily in the U.S. and Canada. Operations are divided into three segments: Over-the-Counter (OTC) Healthcare, Household Cleaning, and Personal Care.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Dec 31, 2007 | 9 Months Ended Dec 31, 2007 |
|---|---|---|
| Total Revenues | $80,222 | $246,170 |
| Net Sales | $79,644 | $244,525 |
| Gross Profit | $41,439 | $127,295 |
| Gross Margin % | 51.7% | 51.7% |
| Operating Income | $22,905 | $66,621 |
| Net Income | $8,419 | $23,568 |
| Diluted EPS | $0.17 | $0.47 |
| Cash from Operating Activities | N/A (3-month data not provided) | $35,306 |
| Total Debt (Outstanding) | $426,225 | $426,225 |
| Cash and Equivalents | $11,554 | $11,554 |
Material Changes vs. Prior Period
- Revenue: For the nine months ended Dec 31, 2007, total revenues increased 2.3% to $246.2 million compared to $240.6 million in the prior year. This growth was primarily driven by the acquisition of the Wartner brand in September 2006. Excluding Wartner, revenues were essentially flat.
- Net Income: Net income for the nine-month period decreased 14.9% to $23.6 million from $27.7 million in the prior year. The decline was attributed to increased advertising spending, higher product costs, and a $1.4 million increase in the allowance for returns related to the voluntary withdrawal of Little Remedies pediatric products.
- Gross Margin: Gross profit margin decreased from 52.5% in the prior year to 51.7% for the nine-month period. This was due to unfavorable sales mix toward lower-margin brands, higher promotional allowances, and inventory obsolescence charges.
- Segment Performance:
- OTC Healthcare: Revenues increased 4.6% (driven by Wartner and Murine Earigate), but gross profit margin declined due to the Little Remedies withdrawal.
- Household Cleaning: Revenues increased 1.5%, but contribution margin decreased due to higher advertising spend for Comet Mildew SprayGel.
- Personal Care: Revenues declined 9.6% due to lower consumption of major brands like Cutex and Denorex.
- Debt Reduction: The Company repaid $34.5 million of its Tranche B Term Loan Facility in excess of normal maturities during the nine-month period, reducing total indebtedness from $463.4 million to $426.2 million.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items:
- Product Withdrawal: In October 2007, the Company voluntarily withdrew two Little Remedies medicated pediatric cough and cold products, resulting in a $1.4 million increase in the allowance for returns and lost sales.
- Stock-Based Compensation: The Company reversed $932,000 of previously recorded stock-based compensation costs because management determined performance goals for restricted stock grants would not be met.
- Liquidity and Capital Resources: The Company maintains $60.0 million of available borrowing capacity under its Revolving Credit Facility and $200.0 million under its Tranche B Term Loan Facility. Management believes cash flows from operations and available borrowings are sufficient to meet obligations for the next 12 months.
- Risks and Contingencies:
- Legal Proceedings: Pending securities class action litigation (mediation held Jan 2008, no settlement reached); OraSure Technologies arbitration concluded with a non-material payment; DenTek Oral Care litigation pending motions to dismiss.
- Concentration Risk: Approximately 23.6% of sales for the nine-month period were made to a single customer. The top 10 manufacturers accounted for 79% of gross sales.
- Interest Rate Risk: The Company has $300.2 million in variable-rate debt. A 1% increase in interest rates would impact pre-tax earnings by approximately $3.0 million, partially mitigated by interest rate caps.
Investor Verification Checklist
- Verify the impact of the Little Remedies product withdrawal on future revenue and return allowances.
- Monitor the status of the pending securities class action litigation and potential settlement costs.
- Assess the sustainability of the Household Cleaning segment's revenue growth given the decline in the Personal Care segment.
- Review the Company's ability to maintain leverage ratios below 4.5:1 as required by its credit facility covenants.
- Confirm the extent of reliance on the single customer representing ~23.6% of sales and the stability of relationships with top 10 manufacturers.